Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies

Patients with unresectable, chemo-refractory colorectal cancer liver metastases (CRCLM) have limited local treatment options. We report our institutional experience on the efficacy of resin-based yttrium-90 ((90)Y) radioembolization for the treatment of CRCLM and our findings on associated circulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Janowski, E., Timofeeva, O., Chasovskikh, S., Goldberg, M., Kim, A., Banovac, F., Pang, D., Dritschilo, A., Unger, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355723/
https://www.ncbi.nlm.nih.gov/pubmed/28004119
http://dx.doi.org/10.3892/or.2016.5284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355723/
https://www.ncbi.nlm.nih.gov/pubmed/28004119
http://dx.doi.org/10.3892/or.2016.5284

Ejemplares similares